Ming De Yu
Vorsitzender bei Chinese Pharmaceutical Enterprises Association
Aktive Positionen von Ming De Yu
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Chinese Pharmaceutical Enterprises Association | Vorsitzender | 01.01.2004 | - |
China Medical Entrepreneur Association | Vorsitzender | - | - |
Karriereverlauf von Ming De Yu
Ehemalige bekannte Positionen von Ming De Yu
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SHANDONG WOHUA PHARMACEUTICAL CO., LTD. | Direktor/Vorstandsmitglied | 25.04.2012 | 06.01.2016 |
Independent Dir/Board Member | 25.04.2012 | 06.01.2016 | |
China Nuokang Bio-Pharmaceutical, Inc.
China Nuokang Bio-Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology China Nuokang Bio-Pharmaceutical, Inc. is a biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hematological and cardiovascular products. It currently sells a portfolio of fourteen products, including three principal products: Baquting, its flagship bleeding control product; Aiduo, its cardiovascular stress imaging agent; and Aiwen, its anti-arrhythmic agent. The company has also entered into an exclusive agreement for the marketing and distribution in China of Kaitong, an intravenous injectable lipid emulsion of vasodilator alprostadil for the treatment of peripheral vascular diseases, cardiocerebral microcirculation disorders and post-surgery thrombosis. Its product pipeline includes four product candidates under development that address the growing market and medical needs for hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. The company was founded on November 1997 and is headquartered in Shenyang, China. | Direktor/Vorstandsmitglied | 23.11.2009 | 01.01.2013 |
Independent Dir/Board Member | 01.08.2008 | 01.01.2013 | |
NORTH CHINA PHARMACEUTICAL COMPANY.LTD | Direktor/Vorstandsmitglied | 21.05.2010 | 01.01.2012 |
Independent Dir/Board Member | 21.10.2011 | 01.01.2012 | |
Fuxin Traditional Chinese Medicine Co. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1983 | 01.01.1983 |
Liaoning Fuxin Pharmaceutical Co. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1983 | 01.01.1983 |
SICHUAN KELUN PHARMACEUTICAL CO., LTD. | Direktor/Vorstandsmitglied | - | - |
Beijing Pharmaceutical Group Co., Ltd.
Beijing Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Pharmaceutical Group Co., Ltd. engages in the sale of Chinese medicines, chemical raw materials, chemical agents, antibiotics, biochemical drugs, and medical equipment. The company was found on March 28, 1987 and is headquartered in Beijing, China. | Direktor/Vorstandsmitglied | 13.12.2010 | - |
Vorsitzender | 16.03.2010 | 13.12.2010 | |
░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Ausbildung von Ming De Yu
Dalian University of Technology | Undergraduate Degree |
Statistik
International
China | 12 |
Operativ
Director/Board Member | 6 |
Independent Dir/Board Member | 4 |
Chairman | 3 |
Sektoral
Health Technology | 7 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
3SBIO INC. | Health Technology |
NORTH CHINA PHARMACEUTICAL COMPANY.LTD | Health Technology |
SICHUAN KELUN PHARMACEUTICAL CO., LTD. | Health Technology |
SHANDONG WOHUA PHARMACEUTICAL CO., LTD. | Health Technology |
Private Unternehmen | 6 |
---|---|
China Nuokang Bio-Pharmaceutical, Inc.
China Nuokang Bio-Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology China Nuokang Bio-Pharmaceutical, Inc. is a biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hematological and cardiovascular products. It currently sells a portfolio of fourteen products, including three principal products: Baquting, its flagship bleeding control product; Aiduo, its cardiovascular stress imaging agent; and Aiwen, its anti-arrhythmic agent. The company has also entered into an exclusive agreement for the marketing and distribution in China of Kaitong, an intravenous injectable lipid emulsion of vasodilator alprostadil for the treatment of peripheral vascular diseases, cardiocerebral microcirculation disorders and post-surgery thrombosis. Its product pipeline includes four product candidates under development that address the growing market and medical needs for hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. The company was founded on November 1997 and is headquartered in Shenyang, China. | Health Technology |
Beijing Pharmaceutical Group Co., Ltd.
Beijing Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Pharmaceutical Group Co., Ltd. engages in the sale of Chinese medicines, chemical raw materials, chemical agents, antibiotics, biochemical drugs, and medical equipment. The company was found on March 28, 1987 and is headquartered in Beijing, China. | Health Technology |
Fuxin Traditional Chinese Medicine Co. | |
Liaoning Fuxin Pharmaceutical Co. | |
Chinese Pharmaceutical Enterprises Association | |
China Medical Entrepreneur Association |
- Börse
- Insiders
- Ming De Yu
- Erfahrung